APOA1 and migraine disorder: Plasma metabolomics in migraine patients indicate decreased levels of apolipoprotein A1, reduced ratios of free cholesteryl esters to total lipids in small HDL subtypes, and significantly decreased omega-3 fatty acids in men only.